Stiles Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Stiles Financial Services's REGN Position: Q3 2026 in Review
Stiles Financial Services reduced its Regeneron Pharmaceuticals (REGN) stake by 8.1% in Q3 2026, selling an estimated $218K and leaving 3,276 shares worth $2.48M. The position accounts for 0.63% of the portfolio, ranked #49.
Stiles Financial Services first reported a position in REGN in Q4 2022 and has held it in 16 quarters since. The position peaked at $3.61M in Q3 2024. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Stiles Financial Services held 3,276 shares of Regeneron Pharmaceuticals worth $2.48M as of Q3 2026.
- Stiles Financial Services sold 288 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $218K.
- Regeneron Pharmaceuticals made up 0.63% of Stiles Financial Services's portfolio in Q3 2026, its #49 holding.
- Stiles Financial Services first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
- Stiles Financial Services's Regeneron Pharmaceuticals position peaked at $3.61M in Q3 2024.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Stiles Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.